Literature DB >> 17378623

CD5-positive B-cell acute lymphoblastic leukemia.

Michael R Peterson1, Kyle J Noskoviak, Robert Newbury.   

Abstract

CD5-positive B-cell acute lymphoblastic leukemia (ALL) is an exceedingly rare entity, with only a single case report in the literature. We report 2 additional cases of CD5-positive B-cell ALL in a 16-year-old male and a 15-year-old female. The 1st case was initially misdiagnosed as Ewing sarcoma due to a lack of CD45 expression and weak expression of CD99. Cytogenetic analysis of the 2nd case revealed trisomy 22, the 1st time this finding has been reported in ALL. Both patients had poor outcomes, as did the patient in the previously published case report. We conclude that CD5-positive B-cell ALL is a rare, aggressive malignancy with a poor prognosis that presents in adolescence. Pathologists and clinicians should be aware of this entity to avoid confusion with other small blue-cell tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17378623     DOI: 10.2350/06-03-0057.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  4 in total

1.  CD5 Positive B Lymphoblastic Leukemia: Report of a Case with Review of Literature.

Authors:  Sreejesh Sreedharanunni; Narender Kumar; Alka Khadwal
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-04       Impact factor: 0.900

2.  Aberrant Immunophenotypic Expression of CD5 in a Case of B Acute Lymphoblastic Leukemia: A Case Report.

Authors:  Deepti Mutreja; Hara Prasad Pati; Divya Bansal; Rahul Kumar Sharma; Sonal Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2014-02-18       Impact factor: 0.900

3.  MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia.

Authors:  Ja-Young Seo; Soo Hyun Lee; Hee-Jin Kim; Keon Hee Yoo; Hong Hoe Koo; Yong Gon Cho; Sam Im Choi; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

4.  Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care center.

Authors:  Karthik Bommannan; Jhansi Rani Arumugam; Venkatraman Radhakrishnan; Jayachandran Perumal Kalaiyarasi; Nikita Mehra; Tenali Gnana Sagar; Shirley Sundersingh
Journal:  Hematol Transfus Cell Ther       Date:  2020-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.